Status:
COMPLETED
Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Collaborating Sponsors:
National Comprehensive Cancer Network
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-74 years
Phase:
NA
Brief Summary
This is a 3-arm randomized trial aimed at increasing rates of participation in colorectal cancer (CRC) screening by outreach to patients' homes using choice architecture informed by behavioral science...
Detailed Description
The investigators will evaluate the effectiveness of mailed outreach with choice between colonoscopy and FIT, and FIT alone, as compared to colonoscopy alone in increasing CRC screening rates.
Eligibility Criteria
Inclusion
- At least 1 visit with CHDC in the past 2 years
- Not up to date on CRC screening (no evidence of colonoscopy in the last 10 years, sigmoidoscopy in the last 5 years, or stool testing in the past 12 months)
Exclusion
- History of CRC or polyps
- Significant family history of CRC
- History of Inflammatory Bowel Disease or Ulcerative Colitis
- History of colectomy
- History of metastatic cancer
- Current use of Medication Assisted Therapy (MAT)
Key Trial Info
Start Date :
October 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2022
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04711473
Start Date
October 27 2021
End Date
November 11 2022
Last Update
January 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Health and Dental Care
Pottstown, Pennsylvania, United States, 19465